{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:00:38Z","timestamp":1761058838328,"version":"3.35.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"S9","license":[{"start":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T00:00:00Z","timestamp":1218499200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2105-9-s9-s8","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T18:12:55Z","timestamp":1218564775000},"source":"Crossref","is-referenced-by-count":36,"title":["Systems biology approach to identification of biomarkers for metastatic progression in cancer"],"prefix":"10.1186","volume":"9","author":[{"given":"Andrey A","family":"Ptitsyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M","family":"Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas H","family":"Thamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,12]]},"reference":[{"issue":"6","key":"2667_CR1","first-page":"423","volume":"16","author":"A Onn","year":"2002","unstructured":"Onn A, Fidler IJ: Metastatic potential of human neoplasms. In Vivo 2002,16(6):423\u2013429.","journal-title":"In Vivo"},{"issue":"6","key":"2667_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003,3(6):453\u2013458. 10.1038\/nrc1098","journal-title":"Nat Rev Cancer"},{"issue":"4306","key":"2667_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.887927","volume":"197","author":"IJ Fidler","year":"1977","unstructured":"Fidler IJ, Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science 1977,197(4306):893\u2013895. 10.1126\/science.887927","journal-title":"Science"},{"issue":"3","key":"2667_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa063994","volume":"356","author":"R Liu","year":"2007","unstructured":"Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF: The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007,356(3):217\u2013226. 10.1056\/NEJMoa063994","journal-title":"N Engl J Med"},{"issue":"1","key":"2667_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4161\/cbt.188","volume":"2","author":"B Parker","year":"2003","unstructured":"Parker B, Sukumar S: Distant metastasis in breast cancer: molecular mechanisms and therapeutic targets. Cancer Biol Ther 2003,2(1):14\u201321.","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"2667_CR6","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/carcin\/bgi377","volume":"27","author":"A Provenzani","year":"2006","unstructured":"Provenzani A, Fronza R, Loreni F, Pascale A, Amadio M, Quattrone A: Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. Carcinogenesis 2006,27(7):1323\u20131333. 10.1093\/carcin\/bgi377","journal-title":"Carcinogenesis"},{"issue":"1","key":"2667_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"S Ramaswamy","year":"2003","unstructured":"Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 2003,33(1):49\u201354. 10.1038\/ng1060","journal-title":"Nat Genet"},{"issue":"6871","key":"2667_CR8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van 't Veer","year":"2002","unstructured":"van 't Veer LJ, Dai H, Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, Kooy K, Marton MJ, Witteveen AT, et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002,415(6871):530\u2013536. 10.1038\/415530a","journal-title":"Nature"},{"issue":"21","key":"2667_CR9","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/jnci\/87.21.1588","volume":"87","author":"IJ Fidler","year":"1995","unstructured":"Fidler IJ: Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst 1995,87(21):1588\u20131592. 10.1093\/jnci\/87.21.1588","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2667_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrc1803","volume":"6","author":"K Hunter","year":"2006","unstructured":"Hunter K: Host genetics influence tumour metastasis. Nat Rev Cancer 2006,6(2):141\u2013146. 10.1038\/nrc1803","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2667_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tig.2006.07.009","volume":"22","author":"NP Crawford","year":"2006","unstructured":"Crawford NP, Hunter KW: New perspectives on hereditary influences in metastatic progression. Trends Genet 2006,22(10):555\u2013561. 10.1016\/j.tig.2006.07.009","journal-title":"Trends Genet"},{"issue":"15","key":"2667_CR12","first-page":"4499","volume":"62","author":"E LaTulippe","year":"2002","unstructured":"LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, Gerald WL: Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 2002,62(15):4499\u20134506.","journal-title":"Cancer Res"},{"issue":"3","key":"2667_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0090-4295(99)00471-9","volume":"55","author":"HI Scher","year":"2000","unstructured":"Scher HI, Heller G: Clinical states in prostate cancer: toward a dynamic model of disease progression. Urology 2000,55(3):323\u2013327. 10.1016\/S0090-4295(99)00471-9","journal-title":"Urology"},{"key":"2667_CR14","first-page":"135","volume-title":"Cancer Principles and Practice of Oncology","author":"IJ Fidler","year":"1997","unstructured":"Fidler IJ: Molecular biology of cancer: invasion and metastasis. In Cancer Principles and Practice of Oncology. Edited by: DeVita VT, Hellman, S, Rosenberg SA. Philadelphia: Lippincott-Raven; 1997:135\u2013152."},{"issue":"2","key":"2667_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0888-7543(02)00021-6","volume":"81","author":"S Draghici","year":"2003","unstructured":"Draghici S, Khatri P, Martins RP, Ostermeier GC, Krawetz SA: Global functional profiling of gene expression. Genomics 2003,81(2):98\u2013104. 10.1016\/S0888-7543(02)00021-6","journal-title":"Genomics"},{"issue":"20","key":"2667_CR16","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1093\/bioinformatics\/btl424","volume":"22","author":"T Manoli","year":"2006","unstructured":"Manoli T, Gretz N, Grone HJ, Kenzelmann M, Eils R, Brors B: Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics 2006,22(20):2500\u20132506. 10.1093\/bioinformatics\/btl424","journal-title":"Bioinformatics"},{"issue":"43","key":"2667_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al.: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005,102(43):15545\u201315550. 10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2667_CR18","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1093\/bioinformatics\/bti260","volume":"21","author":"WT Barry","year":"2005","unstructured":"Barry WT, Nobel AB, Wright FA: Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics 2005,21(9):1943\u20131949. 10.1093\/bioinformatics\/bti260","journal-title":"Bioinformatics"},{"issue":"2","key":"2667_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003,19(2):185\u2013193. 10.1093\/bioinformatics\/19.2.185","journal-title":"Bioinformatics"},{"issue":"1","key":"2667_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2165\/00822942-200403010-00007","volume":"3","author":"S Patel","year":"2004","unstructured":"Patel S, Lyons-Weiler J: caGEDA: a web application for the integrated analysis of global gene expression patterns in cancer. Appl Bioinformatics 2004,3(1):49\u201362.","journal-title":"Appl Bioinformatics"},{"issue":"9","key":"2667_CR21","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","volume":"8","author":"W Huang da","year":"2007","unstructured":"Huang da W, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA: The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 2007,8(9):R183. 10.1186\/gb-2007-8-9-r183","journal-title":"Genome Biol"},{"key":"2667_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/BF01726151","volume":"4","author":"O Warburg","year":"1925","unstructured":"Warburg O: Uber den Stoffwechsel der Carcinomzelle. Klin Wochenschr 1925, 4: 534\u2013536. 10.1007\/BF01726151","journal-title":"Klin Wochenschr"},{"key":"2667_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O: On the origin of cancer cells. Science 1956, 123: 309\u2013314. 10.1126\/science.123.3191.309","journal-title":"Science"},{"key":"2667_CR24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg O: On respiratory impairment in cancer cells. Science 1956, 124: 269\u2013270.","journal-title":"Science"},{"issue":"51","key":"2667_CR25","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1038\/sj.onc.1205983","volume":"21","author":"G Amuthan","year":"2002","unstructured":"Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM, Avadhani NG: Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 2002,21(51):7839\u20137849. 10.1038\/sj.onc.1205983","journal-title":"Oncogene"},{"issue":"10","key":"2667_CR26","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1128\/MCB.20.10.3590-3596.2000","volume":"20","author":"MH Harris","year":"2000","unstructured":"Harris MH, Vander Heiden MG, Kron SJ, Thompson CB: Role of oxidative phosphorylation in Bax toxicity. Mol Cell Biol 2000,20(10):3590\u20133596. 10.1128\/MCB.20.10.3590-3596.2000","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2667_CR27","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.1074\/jbc.275.10.7087","volume":"275","author":"R Dey","year":"2000","unstructured":"Dey R, Moraes CT: Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells. J Biol Chem 2000,275(10):7087\u20137094. 10.1074\/jbc.275.10.7087","journal-title":"J Biol Chem"},{"issue":"1","key":"2667_CR28","first-page":"245","volume":"19","author":"WH Gmeiner","year":"2008","unstructured":"Gmeiner WH, Hellmann GM, Shen P: Tissue-dependent and -independent gene expression changes in metastatic colon cancer. Oncol Rep 2008,19(1):245\u2013251.","journal-title":"Oncol Rep"},{"issue":"6","key":"2667_CR29","first-page":"1541","volume":"17","author":"HM Lin","year":"2007","unstructured":"Lin HM, Chatterjee A, Lin YH, Anjomshoaa A, Fukuzawa R, McCall JL, Reeve AE: Genome wide expression profiling identifies genes associated with colorectal liver metastasis. Oncol Rep 2007,17(6):1541\u20131549.","journal-title":"Oncol Rep"},{"issue":"7","key":"2667_CR30","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/carcin\/bgh113","volume":"25","author":"JM Cuezva","year":"2004","unstructured":"Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, Beer DG: The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis 2004,25(7):1157\u20131163. 10.1093\/carcin\/bgh113","journal-title":"Carcinogenesis"},{"issue":"22","key":"2667_CR31","first-page":"6674","volume":"62","author":"JM Cuezva","year":"2002","unstructured":"Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H, Zapata JM, Marusawa H, Chamorro M, Reed JC: The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 2002,62(22):6674\u20136681.","journal-title":"Cancer Res"},{"issue":"4","key":"2667_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000104457","volume":"53","author":"RE Airley","year":"2007","unstructured":"Airley RE, Mobasheri A: Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007,53(4):233\u2013256. 10.1159\/000104457","journal-title":"Chemotherapy"},{"key":"2667_CR33","volume-title":"Cancer Chemother Pharmacol","author":"X Cao","year":"2008","unstructured":"Cao X, Jia G, Zhang T, Yang M, Wang B, Wassenaar PA, Cheng H, Knopp MV, Sun D: Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model. Cancer Chemother Pharmacol 2008, in press."},{"issue":"3","key":"2667_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","volume":"34","author":"A Duenas-Gonzalez","year":"2008","unstructured":"Duenas-Gonzalez A, Candelaria M, Perez-Plascencia C, Perez-Cardenas E, de la Cruz-Hernandez E, Herrera LA: Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat Rev 2008,34(3):206\u2013222. 10.1016\/j.ctrv.2007.11.003","journal-title":"Cancer Treat Rev"},{"issue":"34","key":"2667_CR35","doi-asserted-by":"publisher","first-page":"24279","DOI":"10.1074\/jbc.M601209200","volume":"281","author":"IK Hong","year":"2006","unstructured":"Hong IK, Jin YJ, Byun HJ, Jeoung DI, Kim YM, Lee H: Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J Biol Chem 2006,281(34):24279\u201324292. 10.1074\/jbc.M601209200","journal-title":"J Biol Chem"},{"issue":"11 Pt 1","key":"2667_CR36","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1055-9965.1717.13.11","volume":"13","author":"J Ang","year":"2004","unstructured":"Ang J, Lijovic M, Ashman LK, Kan K, Frauman AG: CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator? Cancer Epidemiol Biomarkers Prev 2004,13(11 Pt 1):1717\u20131721.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2667_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10911-006-9002-8","volume":"10","author":"SD Merajver","year":"2005","unstructured":"Merajver SD, Usmani SZ: Multifaceted role of Rho proteins in angiogenesis. J Mammary Gland Biol Neoplasia 2005,10(4):291\u2013298. 10.1007\/s10911-006-9002-8","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"11","key":"2667_CR38","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1111\/j.1440-1746.2006.04534.x","volume":"22","author":"D Wang","year":"2007","unstructured":"Wang D, Dou K, Xiang H, Song Z, Zhao Q, Chen Y, Li Y: Involvement of RhoA in progression of human hepatocellular carcinoma. J Gastroenterol Hepatol 2007,22(11):1916\u20131920. 10.1111\/j.1440-1746.2006.04534.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"2667_CR39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10620-007-9887-0","volume":"53","author":"Y Takami","year":"2008","unstructured":"Takami Y, Higashi M, Kumagai S, Kuo PC, Kawana H, Koda K, Miyazaki M, Harigaya K: The activity of RhoA is correlated with lymph node metastasis in human colorectal cancer. Dig Dis Sci 2008,53(2):467\u2013473. 10.1007\/s10620-007-9887-0","journal-title":"Dig Dis Sci"},{"issue":"7","key":"2667_CR40","first-page":"2632","volume":"9","author":"T Kamai","year":"2003","unstructured":"Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, Oshima H: Significant association of Rho\/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 2003,9(7):2632\u20132641.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2667_CR41","first-page":"685","volume":"29","author":"LX Chai","year":"2007","unstructured":"Chai LX, Sun KL, Guo LP, Zhang HT, Lu SX: Expression of ezrin and CD44-v6 in human esophageal squamous cell carcinoma and its clinical significance. Zhonghua Zhong Liu Za Zhi 2007,29(9):685\u2013688.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"5","key":"2667_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jso.20654","volume":"96","author":"N Torer","year":"2007","unstructured":"Torer N, Kayaselcuk F, Nursal TZ, Yildirim S, Tarim A, Noyan T, Karakayali H: Adhesion molecules as prognostic markers in pancreatic adenocarcinoma. J Surg Oncol 2007,96(5):419\u2013423. 10.1002\/jso.20654","journal-title":"J Surg Oncol"},{"issue":"2","key":"2667_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/01.pgp.0000185410.39050.ac","volume":"25","author":"M Kobel","year":"2006","unstructured":"Kobel M, Gradhand E, Zeng K, Schmitt WD, Kriese K, Lantzsch T, Wolters M, Dittmer J, Strauss HG, Thomssen C, et al.: Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int J Gynecol Pathol 2006,25(2):121\u2013130. 10.1097\/01.pgp.0000185410.39050.ac","journal-title":"Int J Gynecol Pathol"},{"issue":"12","key":"2667_CR44","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1001\/archsurg.140.12.1184","volume":"140","author":"TS Yeh","year":"2005","unstructured":"Yeh TS, Tseng JH, Liu NJ, Chen TC, Jan YY, Chen MF: Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Arch Surg 2005,140(12):1184\u20131190. 10.1001\/archsurg.140.12.1184","journal-title":"Arch Surg"},{"issue":"17","key":"2667_CR45","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.1158\/1078-0432.CCR-05-0548","volume":"11","author":"WH Weng","year":"2005","unstructured":"Weng WH, Ahlen J, Astrom K, Lui WO, Larsson C: Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 2005,11(17):6198\u20136204. 10.1158\/1078-0432.CCR-05-0548","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2667_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nm982","volume":"10","author":"C Khanna","year":"2004","unstructured":"Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ: The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004,10(2):182\u2013186. 10.1038\/nm982","journal-title":"Nat Med"},{"key":"2667_CR47","volume-title":"Clin Exp Metastasis","author":"LC Kelley","year":"2008","unstructured":"Kelley LC, Shahab S, Weed SA: Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer. Clin Exp Metastasis 2008, in press."},{"issue":"9","key":"2667_CR48","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/cncr.23410","volume":"112","author":"M Mandal","year":"2008","unstructured":"Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, et al.: Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008,112(9):2088\u20132100. 10.1002\/cncr.23410","journal-title":"Cancer"},{"issue":"24","key":"2667_CR49","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1097\/00029330-200712020-00028","volume":"120","author":"F Xue","year":"7632","unstructured":"Xue F, Zhang JJ, Qiu F, Zhang M, Chen XS, Li QG, Han LZ, Xi ZF, Xia Q: Rho signaling inhibitor, Y-2 inhibits invasiveness of metastastic hepatocellular carcinoma in a mouse model. Chin Med J (Engl) 7632,120(24):2304\u20132307.","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"2667_CR50","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1158\/1535-7163.MCT-06-0782","volume":"6","author":"CR Evelyn","year":"2007","unstructured":"Evelyn CR, Wade SM, Wang Q, Wu M, Iniguez-Lluhi JA, Merajver SD, Neubig RR: CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther 2007,6(8):2249\u20132260. 10.1158\/1535-7163.MCT-06-0782","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"2667_CR51","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1158\/0008-5472.CAN-04-3135","volume":"65","author":"X Wan","year":"2005","unstructured":"Wan X, Mendoza A, Khanna C, Helman LJ: Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res 2005,65(6):2406\u20132411. 10.1158\/0008-5472.CAN-04-3135","journal-title":"Cancer Res"},{"issue":"1","key":"2667_CR52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1479-5876-5-64","volume":"5","author":"AN Khan","year":"2007","unstructured":"Khan AN, Magner WJ, Tomasi TB: An epigenetic vaccine model active in the prevention and treatment of melanoma. J Transl Med 2007,5(1):64. 10.1186\/1479-5876-5-64","journal-title":"J Transl Med"},{"issue":"5","key":"2667_CR53","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00262-007-0402-4","volume":"57","author":"AN Khan","year":"2008","unstructured":"Khan AN, Gregorie CJ, Tomasi TB: Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells. Cancer Immunol Immunother 2008,57(5):647\u2013654. 10.1007\/s00262-007-0402-4","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"2667_CR54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2567.2007.02689.x","volume":"123","author":"J Manning","year":"2008","unstructured":"Manning J, Indrova M, Lubyova B, Pribylova H, Bieblova J, Hejnar J, Simova J, Jandlova T, Bubenik J, Reinis M: Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours. Immunology 2008,123(2):218\u2013227.","journal-title":"Immunology"},{"key":"2667_CR55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini YaH","year":"1995","unstructured":"Benjamini YaH Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 1995, 57: 289\u2013300.","journal-title":"J Roy Stat Soc B"},{"key":"2667_CR56","first-page":"149","volume":"224","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R: Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol 2003, 224: 149\u2013157.","journal-title":"Methods Mol Biol"},{"key":"2667_CR57","volume-title":"Nature Preceedings","author":"ML Adrian Mondry","year":"2007","unstructured":"Adrian Mondry ML, Alessandro Giuliani: DNA expression microarrays may be the wrong tool to identify biological pathways. Nature Preceedings 2007."},{"issue":"15","key":"2667_CR58","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1289\/ehp.6497","volume":"111","author":"W Tong","year":"2003","unstructured":"Tong W, Cao X, Harris S, Sun H, Fang H, Fuscoe J, Harris A, Hong H, Xie Q, Perkins R, et al.: ArrayTrack \u2013 supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect 2003,111(15):1819\u20131826.","journal-title":"Environ Health Perspect"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-9-S9-S8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2105-9-S9-S8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-9-S9-S8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:16:09Z","timestamp":1738325769000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-9-S9-S8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,12]]},"references-count":58,"journal-issue":{"issue":"S9","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["2667"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-9-s9-s8","relation":{},"ISSN":["1471-2105"],"issn-type":[{"type":"electronic","value":"1471-2105"}],"subject":[],"published":{"date-parts":[[2008,8,12]]},"article-number":"S8"}}